Pacira BioSciences, Inc. (PCRX)
NASDAQ: PCRX · Real-Time Price · USD
23.15
-0.49 (-2.07%)
May 8, 2026, 4:00 PM EDT - Market closed
Pacira BioSciences Analyst Ratings
Total Analysts
5
Consensus Rating
Strong Buy
Price Target
$29.40
Upside
+27.00%
Ratings History
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| RBC Capital | RBC Capital | Hold Maintains $22 → $24 | Hold | Maintains | $22 → $24 | +3.67% | May 1, 2026 |
| Needham | Needham | Strong Buy Maintains $30 → $32 | Strong Buy | Maintains | $30 → $32 | +38.23% | May 1, 2026 |
| Barclays | Barclays | Hold Maintains $27 → $25 | Hold | Maintains | $27 → $25 | +7.99% | Mar 26, 2026 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $38 | Strong Buy | Reiterates | $38 | +64.15% | Jan 9, 2026 |
| Needham | Needham | Strong Buy Maintains $30 | Strong Buy | Maintains | $30 | +29.59% | Jan 9, 2026 |
| Barclays | Barclays | Hold Initiates $27 | Hold | Initiates | $27 | +16.63% | Dec 9, 2025 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Initiates $38 | Strong Buy | Initiates | $38 | +64.15% | Nov 17, 2025 |
| Truist Securities | Truist Securities | Strong Buy Maintains $30 → $28 | Strong Buy | Maintains | $30 → $28 | +20.95% | Nov 7, 2025 |
| Needham | Needham | Strong Buy Maintains $32 → $30 | Strong Buy | Maintains | $32 → $30 | +29.59% | May 9, 2025 |
| Needham | Needham | Strong Buy Reiterates $32 | Strong Buy | Reiterates | $32 | +38.23% | Apr 8, 2025 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Maintains $48 → $65 | Strong Buy | Maintains | $48 → $65 | +180.78% | Apr 8, 2025 |
| Barclays | Barclays | Buy Maintains $17 → $24 | Buy | Maintains | $17 → $24 | +3.67% | Feb 28, 2025 |
| Needham | Needham | Strong Buy Maintains $30 → $32 | Strong Buy | Maintains | $30 → $32 | +38.23% | Feb 28, 2025 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Maintains $57 → $70 | Strong Buy | Maintains | $57 → $70 | +202.38% | Feb 28, 2025 |
| Truist Securities | Truist Securities | Strong Sell → Hold Upgrades $8 → $25 | Strong Sell → Hold | Upgrades | $8 → $25 | +7.99% | Jan 30, 2025 |
| RBC Capital | RBC Capital | Hold Reiterates $18 | Hold | Reiterates | $18 | -22.25% | Jan 14, 2025 |
Upgrade to Pro
Get stock forecasts from Wall Street's highest rated professionals
Get much more with Stock Analysis Pro
- Investment ideas from the top Wall Street analysts
- Unlimited access to all data and tools
- Advanced analyst filtering and sorting options
- Up to 10 years of analyst rating history
Analyst Star Rankings
Our analyst star rankings are based on these four factors
- Success Rate
- The percentage of ratings that are profitable.
- Average Return
- The average percentage return within one year of the rating.
- Rating Count
- The more ratings the analyst has provided, the higher the score.
- Recency
- Ratings provided within the past year contribute to a higher score.